AU7896100A - Selective estrogen receptor modulators in the treatment or reduction of the riskof acquiring hypertension, cardiovascular diseases, and insulin resistance - Google Patents

Selective estrogen receptor modulators in the treatment or reduction of the riskof acquiring hypertension, cardiovascular diseases, and insulin resistance

Info

Publication number
AU7896100A
AU7896100A AU78961/00A AU7896100A AU7896100A AU 7896100 A AU7896100 A AU 7896100A AU 78961/00 A AU78961/00 A AU 78961/00A AU 7896100 A AU7896100 A AU 7896100A AU 7896100 A AU7896100 A AU 7896100A
Authority
AU
Australia
Prior art keywords
riskof
hypertension
acquiring
reduction
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU78961/00A
Other languages
English (en)
Inventor
Fernand Labrie
Andre Marette
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Endorecherche Inc
Original Assignee
Endorecherche Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Endorecherche Inc filed Critical Endorecherche Inc
Publication of AU7896100A publication Critical patent/AU7896100A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU78961/00A 1999-10-14 2000-10-13 Selective estrogen receptor modulators in the treatment or reduction of the riskof acquiring hypertension, cardiovascular diseases, and insulin resistance Abandoned AU7896100A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15935999P 1999-10-14 1999-10-14
US60159359 1999-10-14
PCT/CA2000/001222 WO2001026651A2 (fr) 1999-10-14 2000-10-13 Modulateurs selectifs des recepteurs oestrogeniques pour traiter l'hypertension, des maladies cardio-vasculaires et la resistance a l'insuline ou reduire le risque de contracter ces maladies

Publications (1)

Publication Number Publication Date
AU7896100A true AU7896100A (en) 2001-04-23

Family

ID=22572268

Family Applications (1)

Application Number Title Priority Date Filing Date
AU78961/00A Abandoned AU7896100A (en) 1999-10-14 2000-10-13 Selective estrogen receptor modulators in the treatment or reduction of the riskof acquiring hypertension, cardiovascular diseases, and insulin resistance

Country Status (2)

Country Link
AU (1) AU7896100A (fr)
WO (1) WO2001026651A2 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6465445B1 (en) * 1998-06-11 2002-10-15 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US6358991B2 (en) * 2000-07-06 2002-03-19 American Home Products Corporation Methods of treating neuropeptide Y-related conditions
AU7178301A (en) * 2000-07-06 2002-01-21 American Home Prod Methods for increasing nitric oxide synthase activity
CZ2004220A3 (cs) 2001-08-11 2004-06-16 Bristol-Myers Squibb Pharma Company Název neuveden
US20080227814A1 (en) * 2004-01-29 2008-09-18 Jeffrey Alan Dodge Selective Estrogen Receptor Modulators
US8080675B2 (en) 2004-09-21 2011-12-20 Marshall Edwards, Inc. Chroman derivatives, medicaments and use in therapy
ATE532777T1 (de) 2004-09-21 2011-11-15 Marshall Edwards Inc Substituierte chromanderivate, medikamente und anwendungen in der therapie
JP4874958B2 (ja) 2005-03-30 2012-02-15 エーザイ・アール・アンド・ディー・マネジメント株式会社 ピリジン誘導体を含有する抗真菌剤
TW200740442A (en) * 2005-08-29 2007-11-01 Taiho Pharmaceutical Co Ltd Therapeutic agent for hypertension
CN101360488A (zh) * 2005-11-22 2009-02-04 史密丝克莱恩比彻姆公司 化合物
US20100317635A1 (en) * 2009-06-16 2010-12-16 Endorecherche, Inc. Treatment of hot flushes, vasomotor symptoms, and night sweats with sex steroid precursors in combination with selective estrogen receptor modulators
KR101698238B1 (ko) 2010-06-10 2017-01-19 세라곤 파마슈티컬스, 인크. 에스트로겐 수용체 조정제 및 이의 용도
WO2011159769A2 (fr) 2010-06-17 2011-12-22 Aragon Pharmaceuticals, Inc. Modulateurs de récepteur d'œstrogène d'indane et utilisations de ceux-ci
EP2635121B1 (fr) 2010-11-01 2020-01-08 MEI Pharma, Inc. Composés d'isoflavonoïdes et procédés pour le traitement du cancer
SG11201403002RA (en) 2011-12-14 2014-07-30 Seragon Pharmaceuticals Inc Fluorinated estrogen receptor modulators and uses thereof
AU2012353660A1 (en) 2011-12-16 2014-06-12 Olema Pharmaceuticals, Inc. Novel benzopyran compounds, compositions and uses thereof
PL3253208T3 (pl) 2015-02-02 2021-11-08 Mei Pharma, Inc. Terapie kombinowane do zastosowania w leczeniu nowotworu piersi

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4507289A (en) * 1983-12-28 1985-03-26 Progenics, Inc. Treatment of diabetes and other symptoms of hypercorticoidism using a synergistic combination of etiocholanolones and estrogen
US6060503A (en) * 1991-12-02 2000-05-09 Endorecherche, Inc. Benzopyran-containing compounds and method for their use
CN1100541C (zh) * 1993-01-19 2003-02-05 恩多研究公司 脱氢表雄酮的治疗用途和传送系统
ZA944377B (en) * 1993-06-24 1995-12-20 Lilly Co Eli Hypoglycemic agents
US5446061A (en) * 1993-11-05 1995-08-29 Eli Lilly And Company Methods for lowering serum cholesterol
US6562862B1 (en) * 1994-10-20 2003-05-13 Eli Lilly And Company Methods of inhibiting physiological conditions associated with an excess of neuropeptide Y
US5840747A (en) * 1995-06-07 1998-11-24 Eli Lilly And Company Calcium channel antagonists
CA2217810A1 (fr) * 1996-10-10 1998-04-10 Eli Lilly And Company Composes 2-aryl-3-aminoaryloxynaphtyliques, intermediaires, compositions et methodes
JPH10204082A (ja) * 1996-10-25 1998-08-04 Eli Lilly & Co 選択的エストロゲンレセプターモジュレーターとしての活性を有する置換されたベンゾ［ｂ］チオフェン化合物
US5908859A (en) * 1997-08-11 1999-06-01 Eli Lilly And Company Benzothiophenes for inhibiting hyperlipidemia
ID24978A (id) * 1997-11-14 2000-08-31 Lilly Co Eli 2-ARYL-3-AROYLBENZO (b) THIOPHENES BERGUNA UNTUK PENGOBATAN SINDROM DEPRIVASI ESTROGEN
AU4127499A (en) * 1998-06-11 1999-12-30 Endorecherche Inc. Pharmaceutical compositions and uses for androst-5-ene-3beta,17beta-diol
US6465445B1 (en) * 1998-06-11 2002-10-15 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
CN1390126B (zh) * 1999-07-06 2012-06-13 恩多研究公司 选择性雌激素受体调节剂在制备用于治疗或降低肥胖症发展危险性的药物中的用途

Also Published As

Publication number Publication date
WO2001026651A2 (fr) 2001-04-19
WO2001026651A3 (fr) 2001-11-08

Similar Documents

Publication Publication Date Title
AU7896100A (en) Selective estrogen receptor modulators in the treatment or reduction of the riskof acquiring hypertension, cardiovascular diseases, and insulin resistance
AU3779399A (en) Drug-containing transdermal patches, plastisols and adhesives
AU3886599A (en) Silicone adhesives, articles, and methods
AUPQ090499A0 (en) Heart assist device and system
HK1048999A1 (zh) 氮雜䓬吲衍生物，它們的製備和應用
AU2922600A (en) Pyridopyranoazepine derivatives, preparation and therapeutic use
HUP0102549A3 (en) Platinum complex, its preparation and therapeutic application
AU715620C (en) Therapeutic methods and uses
AU9633098A (en) Benzoxazine derivatives, preparation and application in therapy
ZA200003706B (en) Cyclobutene derivatives, their preparation and their therapeutic uses.
HK1031725A1 (en) 3-amino-3-arylpropan-1-ol-derivates, their preparation and their use
AU3301700A (en) (n)-sulfonyl-dipeptide derivatives, production and use thereof in therapy
AU6635800A (en) Pyridomorphinans, thienomoprhinans and use thereof
AU7748200A (en) Hypoxia-related human genes, proteins, and uses thereof
AU3971500A (en) Indazole derivatives, preparation and therapeutic application thereof
TWI320413B (en) 1,4-diazabicyclo [ 3.2.2 ] nonanecarboxamide derivatives, preparation thereof and therapeutic use thereof
HUP0201762A3 (en) Platinum complex, its preparation and therapeutic application
ZA200110271B (en) Substituted 3-pyridyl-4-arylpyrroles, and related therapeutic and prophylatic methods.
IL165779A0 (en) Steroid conjugate, preparation thereof and the usethereof
HUP0203468A3 (en) Betha-d-5-thioxylose derivatives, preparation method and therapeutic use thereof
AU5876899A (en) Polymorphisms in the human alpha4 integrin subunit gene, suitable for diagnosis and treatment of integrin ligand mediated diseases
AU2092200A (en) Use of estrogens and delta-gonadien-21-ol-3,20-diones
SI1043306T1 (en) 3-amino-3-arylpropan-1-ol-derivates, their preparation and use
AU2526001A (en) 2-phenyl-quinoline derivatives, preparation method and therapeutic use thereof
AU2922700A (en) Cyclobutene-3,4-dione derivatives, preparation method and therapeutic use

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase